Article info

Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer

Authors

  1. Correspondence to Professor Dr Peter Wild, Institute of Surgical Pathology, University Hospital Zurich, Schmelzbergstrasse 12, Zurich 8091, Switzerland; peter.wild{at}usz.ch
View Full Text

Citation

Poyet C, Buser L, Roudnicky F, et al
Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer

Publication history

  • Received January 26, 2015
  • Revised April 28, 2015
  • Accepted May 25, 2015
  • First published August 6, 2015.
Online issue publication 
September 18, 2015

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

  • Abstract in Deutsch

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.